Jennison Associates
MYGN icon

Jennison Associates’s Myriad Genetics MYGN Stock Holding History

Jennison Associates’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-60,811
Closed -$539K – 620
2025
Q1 		$539K Buy
60,811
+1,796
+3% +$21.6K ﹤0.01% 547
2024
Q4 		$809K Buy
59,015
+34,853
+144% +$643K ﹤0.01% 510
2024
Q3 		$662K Buy
+24,162
New +$654K ﹤0.01% 531
2019
Q1 		– Sell
-16,388
Closed -$476K – 674
2018
Q4 		$476K Sell
16,388
-1,069
-6% -$38.5K ﹤0.01% 621
2018
Q3 		$803K Sell
17,457
-11,147
-39% -$496K ﹤0.01% 571
2018
Q2 		$1.07M Buy
28,604
+613
+2% +$20.7K ﹤0.01% 564
2018
Q1 		$827K Buy
+27,991
New +$947K ﹤0.01% 571

Other funds holding MYGN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return